Testing for Noncoding RNA Improves Cancer Detection
University of California - Santa Cruz
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
Easy-to-implement technology reduces the per-reaction cost of target capture by two to three orders of magnitude as compared to commercial solutions